Floatz logo

DEXAMETHASONE

Hematopoietic Cell Transplantation Recipient

Indiana UniversitySmall moleculePhase 2Active
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Hematopoietic Cell Transplantation Recipient cohort.

Asset / SponsorPhaseRating
cc-5013
Stanford University
Phase 2BB
Cediranib
Ohio State University Comprehensive Cancer Center
Phase 2BB
mln9708
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 2B
Ibrutinib
Andrew Rezvani
Phase 2B
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
City of Hope Medical Center
Phase 2CCC

View all 12 →

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →